Apposite Capital-backed Kelso Pharma completed the acquisition of UK pharma business form ALTURiX.

Apposite Capital-backed Kelso Pharma, a specialty pharma business, completed the acquisition of UK pharma business form ALTURiX, a pharmaceutical company. Financial terms were not disclosed. “We are pleased to support this next strategic move for Kelso Pharma as its experienced management team builds a specialty pharma business of scale,” Sam Gray, Apposite Managing Partner.